The Asia-Pacific animal vaccines market is poised to reach $1303.27 Million by 2020 from $919.72 Million in 2015, at a CAGR of 7.22% from 2015 to 2020. It has seen significant growth over the past few years, due to fear of imminent epidemics that have led to substantial losses particularly in poultry segment. Veterinary vaccine market’s substantial growth can be attributed to increasing husbandry practices and better management of farms. This marks the estimation of further growth in the market due to advancement in biotechnological research.
Request a sample of this report @ http://www.orbisresearch.com/contacts/request-sample/292960 .
Large breeding companies, out of overall consideration based on economic benefits, are increasingly inclined to buy high-quality market-oriented vaccines which are 5-15 times as expensive as vaccines purchased under policy. Local animal vaccine companies are also scaling up efforts for research and development, making their presence in high-end vaccines and expanding varieties of vaccines. There were 25 kinds of registered animal vaccines in China in 2015, including 10 kinds of pig vaccines, 10 kinds of poultry vaccines, and 5 kinds of other animal vaccines. Moreover, great progress has been made in pet vaccines. On a major note, Rabies vaccines are expected to be approved and go on the market at the end of 2016 or in 2017. On other hand rapid industrialization of the entire livestock segment, an impending shift to internationally acclaimed practices; increased realization among progressive farmers about disease management and prevention and more animal diseases being taken up by federal as well as state governments for mass vaccination programs are increasing the market in India. However, rising maintenance costs for the storage of vaccines, increasing adoption of vegetarian diet in major economies owing to risk of obesity and other chronic diseases are key restraints of the market in this region.
Browse the full report @ http://www.orbisresearch.com/reports/index/asia-pacific-veterinary-vaccines-market-by-type-by-technology-and-by-region-industry-analysis-size-share-growth-trends-and-forecasts-2016-2021 .
The Asia-Pacific veterinary vaccines market has been categorized as livestock and companion vaccines. Further, the livestock vaccines segment has been segmented into five categories namely, bovine, porcine, ovine, poultry and equine. The companion animal vaccines segment has also been further categorized into feline and canine vaccines. In addition, based on production technologies the market is segmented as live attenuated vaccines, inactivated vaccines, recombinant vaccines, toxoid vaccines, subunit vaccines, DNA vaccines and conjugate vaccines. The canine vaccines segment accounted for a slightly larger share (in terms of revenue) than the feline vaccines segment, due to higher average cost allied with canine vaccination. Similarly, the bovine vaccines sub-segment accounted for the largest share (in terms of revenue), followed by porcine. Furthermore, on the basis of geography, the Asia-Pacific Market is analysed under various regions namely, India, China, Japan and South Korea.
Purchase a copy of this report @ http://www.orbisresearch.com/contact/purchase/292960 .
Some of the key players influencing the market are Bayer HealthCare AG, Bioniche Animal Health Canada, Sanofi Animal Health, Inc., Biogenesis Bago SA, Heska Corporation, Indian Immunologicals Ltd., Boehringer Ingelheim GmbH, Zoetis, Novartis Animal Heath, Inc., Merck & Co. Inc, and Protein Sciences.
For any enquires before buying, connect with us @ email@example.com
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +912064101019
For more information contact firstname.lastname@example.org